Viewing Study NCT05100303


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-01-04 @ 11:08 PM
Study NCT ID: NCT05100303
Status: UNKNOWN
Last Update Posted: 2021-10-29
First Post: 2021-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module